Walro D S, Herzog N K, Zhang J, Lim M Y, Bose H R
Department of Microbiology, University of Texas at Austin 78712.
Virology. 1987 Oct;160(2):433-44. doi: 10.1016/0042-6822(87)90015-8.
We have identified the product (p57v-rel) of the transforming gene, v-rel, of avian reticuloendotheliosis virus (REV-T) using antisera generated against nonoverlapping sequences representing the middle and carboxy-terminal regions of the v-rel protein expressed in Escherichia coli (N.K. Herzog and H.R. Bose, Jr., 1986, Proc. Natl. Acad. Sci. USA 83, 812-816). The amino-terminal region of the v-rel protein was also expressed in E. coli and used to generate antisera. The immunoglobulin-enriched fractions of these antisera were used to determine the subcellular location of p57v-rel in REV-T transformed lymphoid cells. Cells were fractionated into nuclear, mitochondrial, microsomal, and cytoplasmic fractions. The majority of p57v-rel was found in the cytoplasm. Examination of REV-T transformed lymphoid cells labeled with 32Pi revealed that the majority of the phosphorylated form of the v-rel protein was also found in the cytoplasm. Indirect immunofluorescence of REV-T transformed cells gave a diffuse cytoplasmic pattern indicating that p57v-rel was not associated with any discrete cellular organelle. The distribution of p57v-rel was similar in REV-T transformed lymphoid cells labeled with [35S]methionine for short and long periods of time, suggesting that p57v-rel is a soluble cytoplasmic protein throughout its lifetime. The v-rel protein was phosphorylated when immune complexes precipitated from transformed cells with the immunoglobulin fractions obtained from antisera against the amino-terminal, middle, and carboxy-terminal regions of v-rel were incubated with [gamma-32P]ATP and Mn2+. The phosphorylation of p57v-rel in the in vitro immune complex kinase assay was inhibited when the immunoglobulin-enriched fraction of these antisera was preincubated with the homologous v-rel fusion proteins. Preincubation with heterologous proteins did not block the phosphorylation of p57v-rel. These observations suggest that p57v-rel is associated with a protein kinase activity. Most of the kinase activity was found in the soluble cytoplasmic fraction of transformed cells. The transforming protein encoded by v-rel is a relatively stable protein with a half-life of approximately 7 to 8 hr in transformed lymphoid cells.
我们利用针对在大肠杆菌中表达的v-rel蛋白的中间和羧基末端区域的非重叠序列产生的抗血清,鉴定了禽网状内皮组织增生症病毒(REV-T)的转化基因v-rel的产物(p57v-rel)(N.K. 赫尔佐格和H.R. 博斯,Jr.,1986年,《美国国家科学院院刊》83,812 - 816)。v-rel蛋白的氨基末端区域也在大肠杆菌中表达并用于产生抗血清。这些抗血清的免疫球蛋白富集部分用于确定p57v-rel在REV-T转化的淋巴细胞中的亚细胞定位。细胞被分离成核、线粒体、微粒体和细胞质部分。发现大多数p57v-rel存在于细胞质中。对用32Pi标记的REV-T转化的淋巴细胞的检查表明,v-rel蛋白的磷酸化形式也大多存在于细胞质中。REV-T转化细胞的间接免疫荧光呈现出弥漫性的细胞质模式,表明p57v-rel不与任何离散的细胞器相关联。在用[35S]甲硫氨酸短期和长期标记的REV-T转化的淋巴细胞中,p57v-rel的分布相似,这表明p57v-rel在其整个生命周期中都是一种可溶性细胞质蛋白。当用从针对v-rel的氨基末端、中间和羧基末端区域的抗血清获得的免疫球蛋白部分从转化细胞中沉淀的免疫复合物与[γ-32P]ATP和Mn2+一起孵育时,v-rel蛋白被磷酸化。当这些抗血清的免疫球蛋白富集部分与同源v-rel融合蛋白预孵育时,体外免疫复合物激酶测定中p57v-rel的磷酸化受到抑制。与异源蛋白预孵育不会阻断p57v-rel的磷酸化。这些观察结果表明p57v-rel与一种蛋白激酶活性相关。大多数激酶活性存在于转化细胞的可溶性细胞质部分。由v-rel编码的转化蛋白是一种相对稳定的蛋白,在转化的淋巴细胞中的半衰期约为7至8小时。